5-Amino-1MQ is a small-molecule compound widely used in research as a selective inhibitor of nicotinamide N-methyltransferase (NNMT). NNMT is a cytosolic, SAM-dependent methyltransferase that catalyzes the methylation of nicotinamide and related heterocycles, producing metabolites such as 1-methylnicotinamide (1-MNA). Through this activity, NNMT directly influences NAD⁺ salvage, methionine cycle flux, and cellular methyl-group balance.
Because of its central metabolic role, NNMT is most highly expressed in the liver, but meaningful expression is also found in adipose tissue, kidney, brain, lung, heart, and skeletal muscle. Elevated NNMT expression and activity have been linked to multiple chronic disease states, making NNMT a well-validated target for mechanistic and therapeutic research.
Why NNMT Matters in Metabolism and Disease
Research has connected upregulated NNMT activity with a range of pathological conditions, including:
- Obesity and type-2 diabetes
- Metabolic syndrome
- Cardiovascular disease
- Kidney disease
- Neurodegenerative disorders, including Parkinson’s disease
- Cancer progression, where NNMT overexpression has been associated with enhanced cell proliferation and poor prognosis in multiple tumor models
One proposed mechanism is that excessive NNMT activity diverts nicotinamide away from NAD⁺ biosynthesis while simultaneously depleting SAM, disrupting both cellular energy metabolism and methylation balance.
5-Amino-1MQ in Obesity and Weight-Loss Research
NNMT has emerged as a compelling target in obesity research. Multiple studies report that NNMT expression and 1-MNA levels are significantly elevated in obesity and insulin-resistant states.
Key preclinical findings include:
- Genetic or pharmacologic NNMT suppression reduces body-weight gain and fat mass in high-fat-diet mouse models
- NNMT inhibition increases intracellular NAD⁺ and SAM levels in adipocytes
- Diet-induced obese (DIO) mice treated with NNMT inhibitors showed:
- 30% reduction in adipocyte size
- 40% reduction in adipocyte volume
- ~30% reduction in total cholesterol
- 50–70% reduction in lipogenesis in adipocyte cultures
Importantly, these metabolic improvements occurred without reductions in food intake, suggesting that NNMT inhibition increases energy expenditure and metabolic flux, rather than suppressing appetite.
These data support the use of 5-Amino-1MQ as a molecular probe to study how NNMT controls adipocyte metabolism, NAD⁺ availability, and systemic energy balance.
5-Amino-1MQ and Muscle Stem Cell (MuSC) Regeneration
Age-related muscle loss and impaired recovery are strongly linked to dysfunction of muscle stem cells (satellite cells). With aging, MuSCs lose their capacity to proliferate, differentiate, and fuse effectively following injury.
In a pivotal study using aged (24-month-old) mice:
- Animals treated with an NNMT inhibitor after acute muscle injury showed:
- Increased MuSC proliferation and fusion
- Nearly 2-fold increases in myofiber cross-sectional area
- A shift toward larger, healthier muscle fibers
- ~70% increase in peak muscle torque compared to controls
These improvements translated into measurably better functional recovery, demonstrating that NNMT inhibition can reactivate senescent muscle stem cells in aged tissue.
NNMT Inhibition and Age-Related Muscle Loss (Sarcopenia)
Sarcopenia—the progressive loss of muscle mass and strength with aging—is closely tied to chronic inflammation and mitochondrial dysfunction. Research has linked impaired mitochondrial quality control and reduced clearance of damaged mitochondria to inflammatory signaling and muscle atrophy.
Lowering NNMT activity has been shown to:
- Improve mitochondrial metabolic signaling
- Enhance regenerative capacity of aged muscle tissue
- Support neuromuscular function during recovery and training
- Promote repair processes following injury
Collectively, these findings position 5-Amino-1MQ and related NNMT inhibitors as valuable tools for investigating muscle aging, regeneration, and metabolic resilience.
Research Significance
Across multiple disease and aging models, NNMT inhibition appears to converge on a few central mechanisms:
- Restoration of NAD⁺ availability
- Preservation of SAM-dependent methylation balance
- Improved mitochondrial and cellular metabolism
- Enhanced tissue regeneration capacity
While these results are preclinical, they strongly support continued use of 5-Amino-1MQ as a research compound for studying metabolic disease, obesity, muscle regeneration, and age-related functional decline.
Research-Grade 5-Amino-1MQ in the USA
For laboratories and investigators seeking high-purity NNMT inhibitors, CombatResearch.is is the best place to shop peptides and research compounds in the USA. Combat Research focuses on quality, consistency, and reliability—so your work starts with materials you can trust.
